chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client was vaccinated at approximately 1210 with her second dose of Pfizer. Client waited for 15 minutes, felt a little dizzy when stood up to leave, but proceeded to leave. she and her boyfriend, , got in car to leave, and she felt worse; nauseous and dizzy. Boyfriend brought her back in to clinic. She was seated down, vitals taken at 1235: O2-98, P-88, BP-130/86. Client was given a water bottle and moved to a couch. She lied down with her feet elevated and cool cloths put on her forehead, back of neck, and lower back. She stated that her injection site was itching; band aid was removed and arm wiped clean. Client stated that she has a hx of latex allergy, hypoglycemia, and that her BS had been irregular the last few days. She stated that she had eaten a chicken sandwich and fries before coming to clinic. She is on prenatal vitamins, but unsure if she is pregnant at the time. Client was given some crackers, and sat up on the couch. Vitals were taken again at 1250: O2-98, P-66, BP-118/78. Clients color had returned and was feeling better. Client stayed until approximately 1315 and was advised to rest, get plenty of fluid and make sure to eat a little more food.
I went to store had the 3 shot COVID and waited my 15 minutes. After that you went home and had the regular body aches of the vaccine. There somewhat more dramatic than the other two vaccines. About three weeks after I went to see a Neurologist due to that I had a Peripheral Neuropathy all over my body. Also, I had lost some vision on my left eye for a short period of time. The Neurologist did multiple tests on me that were the results of the Peripheral Neuropathy. I was also sent to see the Hematologist. The Hematologist said I had a monoclonal gamma globulin test spike. The Hematologist did scans and a bone marrow on me where these results came from. As of today, the adverse events still persist. I am still monitored for the diagnosis.
first caught covid from husband May 22, took paxlovid (but 2/3 dose due to lessened kidney function), had 'rebound' covid that started June 1.  early hours of june 8 woke gasping for breath like a fish out of water, and whooping, for 5-7 minutes.  transported to ER.  blood tests normal.  chest xray showed bronchial inflammation. doxycyclate h. administered, tablets for ten days.
At site of injection: erythema 2 inches across and 2.5 inches shoulder to elbow surrounding injection sight.; At site of injection: intense itching; intermittant tenderness @ the injection sight; Chills; This spontaneous case was reported by a nurse and describes the occurrence of INJECTION SITE PRURITUS (At site of injection: intense itching), VACCINATION SITE PAIN (intermittant tenderness @ the injection sight), VACCINATION SITE ERYTHEMA (At site of injection: erythema 2 inches across and 2.5 inches shoulder to elbow surrounding injection sight.) and CHILLS (Chills) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: SHINGRIX (Injection site (L bicep)) in 2010. Concurrent medical conditions included Hypertension. Concomitant products included HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL/HCTZ) for Hypertension.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced CHILLS (Chills). On 20-Feb-2021, the patient experienced INJECTION SITE PRURITUS (At site of injection: intense itching) and VACCINATION SITE PAIN (intermittant tenderness @ the injection sight). On 20-Feb-2021 at 4:00 PM, the patient experienced VACCINATION SITE ERYTHEMA (At site of injection: erythema 2 inches across and 2.5 inches shoulder to elbow surrounding injection sight.). On 13-Feb-2021, CHILLS (Chills) had resolved. On 01-Mar-2021, INJECTION SITE PRURITUS (At site of injection: intense itching) and VACCINATION SITE ERYTHEMA (At site of injection: erythema 2 inches across and 2.5 inches shoulder to elbow surrounding injection sight.) had resolved. At the time of the report, VACCINATION SITE PAIN (intermittant tenderness @ the injection sight) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient reported having strong reactions to seasonal flu vaccines that included tenderness and swollen clavicular lymph nodes lasting 4 to 6 weeks.  The patient continued to experience intermittent vaccination site tenderness.  The patient reported not seeking any treatment for the adverse events.   This case was linked to MOD-2021-201104 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: Follow-up information received provided event details and outcome, patient history, suspect and concomitant medication dosage details.
With the first vaccine I only experienced significant muscle pain in the left arm where the injection was given.; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 23Jan2021 at 12:00 as dose 1, single (Batch/Lot number: unknown) at the age of 44 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "polyarthralgia" (unspecified if ongoing); "hypertension" (unspecified if ongoing), notes: experiencing medication resistant hypertension later on as well. Concomitant medication(s) included: LEVOTHYROXINE. The following information was reported: MYALGIA (medically significant), outcome "unknown", described as "With the first vaccine I only experienced significant muscle pain in the left arm where the injection was given". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (07Apr2021) Positive, notes: Blood test covid test name post vaccination: Unknown. No other vaccine in four weeks. With the first vaccine I only experienced significant muscle pain in the left arm where the injection was given. Without any history of RA or OA, I have continued to have severe polyarthralgia to this day, with my joints popping and cracking in addition to the pain. I also began experiencing medication resistant hypertension later on as well. No covid prior vaccination. No known allergies.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on available information, a possible contributory role of subject product, BNT162B2 vaccine,  cannot be excluded for the reported event of myalgia, based on temporal relationship and the known product safety profile. There is limited information provided in this report.  This case will be reassessed upon receipt of follow-up information.  ,Linked Report(s) : US-PFIZER INC-202300133156 Same product, patient, different AEs, different dose;US-PFIZER INC-202300135597 Same product, patient and different event;
Initial information received on 12-Mar-2019 regarding an unsolicited valid non-serious case received from a nurse. This case is linked to case 2019SA074207 (same reporter). This case involves a 46 years old female patient who experienced arm pain and wound, while she received vaccine ADACEL. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 07-Dec-2018, the patient received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (lot U5729BA, Exp. Date 21-Jul-2019) via unknown route in the right arm. On an unknown date, the patient developed a non-serious arm pain (vaccination site pain) and wound (unknown latency) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. Other relevant tests not reported. Final diagnosis was arm pain and wound. It was not reported if the patient received a corrective treatment. The patient outcome was not recovered for arm pain and not reported for wound. List of documents held by sender: none.
on day following vax 18hr, pt had a gen tonic/clonic sz followed by a 2nd tonic clonic sz approx 25hr p/vax;
Pt. developed hive-like reaction at injection site of KINRIX. Advised to use BENADRYL.
During administration, the syringe came apart and the vax splashed onto the skin and into the eye of pts father. Water was used to cleanse the skin and irrigate the eye. Child's father stated his eye's felt weird.
A rash on my back and neck; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH (A rash on my back and neck) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (A rash on my back and neck). At the time of the report, RASH (A rash on my back and neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
The next day after the shot on 08/10/2021 i had a big lump behind my head that lasted 3 weeks. Also i started having heart issues. The heart issues got worse within time. To where I ended up in the hospital multiple times. On 10/09/2022 i ended up in the hospital and got diagnosed with SVT. Heart rate of 247. I'm seeing a cardiologist  and now they are talking about possible surgery.  I rapid heart rates about 5 times a week all in the range of 130 and above.
According to the patient the injection site swelled up, was very warm, and became discolored. The area was about the size of a soft ball in width. As of 2/3/17 the area is about 3 inches wide, circular, and discolored. It is not raised, painful, or itchy.
Severe diarrhea starting at 0700 on Feb  11, 14 hours after receiving shot.  Lethargic, weakness, no energy. Moderate soreness at vaccination site.
high temperature of 99.1 F; Patient is under 18 years of age; A spontaneous report  was received from a consumer concerning a 15-year-old male who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced temperature of 99.1 degree Fahrenheit.  The patient is handicapped, and his medical history was not provided. No relevant concomitant medications were reported.  On 03 Feb 2021, patient's mother called and informed that her son was administered Moderna covid-19 vaccine 1st dose on 05 Jan 2021 and 2nd dose on 02 Feb 2021. The patient experienced high temperature of 99.1degree Fahrenheit on 03 Feb 2021. Patient was given Tylenol to treat symptoms.   Action taken with Moderna Covid-19 vaccine was not applicable as patient already received both doses of vaccine.  The outcome of the events temperature of 99.1 degree Fahrenheit was reported as unknown and  inappropriate age at vaccination was  consider as resolved.; Reporter's Comments: This case concerns a 15 year old male who received 1st dose on 05 Jan 2021 and 2nd dose on 02 Feb 2021 of the Moderna Covid-10 vaccine and experienced the non-serious listed event of fever on 03Feb2021 one day later. There were no other reported adverse events in this case of product administered to patient of inappropriate age.
ADMINISTRATION OF AN EXPIRED VACCINE; This spontaneous report received from a health care professional concerned a 24 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, expiry: 21-SEP-2021) dose was not reported, administered on 06-OCT-2021 for prophylactic vaccination. No concomitant medications were reported. On 06-OCT-2021, the patient experienced administration of an expired vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of an expired vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20211014509, 20211015239, 20211014463 and 20211015303.
"hot", presyncope, lightheadedness. Evaluated by EMS-Refusal to transport.
phlebitis in axilla to around chest;initially very painful;pain dec as of 2MAR95;local rxn size of quarter;25APR95 f/u both doses given in lt deltoid & both w/4cm surrounding erythema;
Patient returned to clinic concerned about a possible Vaccine reaction beginning 24-30 hours after Hep B vaccine administered.  Multiple 2-8mm erythematous itching papules on forearms only.  No swelling or dyspnea.  Temp 97.7.  Felt "out of it" over the weekend.  Was skateboarding in a c8ity park.
Had DTAP/IPV, MMR, VAR on 3/30/10. On 4/2 came in w/reaction to arm w/DTAP. Dr. figured reaction to Tet. Redness and cellulitis to arm at injection site only of DTAP/IPV area.
Dose 1: Moderate pain at injection site 24h post-injection. Diminished pain after 48h. Fully resolved after 72h.  Dose 2: Injection site bruising immediately. Significant pain requiring Tylenol, red rash extending ~10mm around injection site, and significant swelling  3h post-injection. Pain and swelling largely resolved after 48h. Rash less extreme, but now circular around injection site and itchy 120h post-injection (current time). Topical hydrocortisone applied to manage discomfort.
Patient seen at urgent care - fever 99, rash - scattered red papules, slightly elevated/blisters in center - 7/16/08.
COVID 19 Treatment/Covid symptoms, Fever; COVID 19 Treatment/Covid symptoms, Fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality. The reporter is the patient.  A 71-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 19Jan2021 at 09:15 as dose 1, single (Lot number: EL3247), in left arm, on 09Feb2021 at 08:15 as dose 2, single (Lot number: EL8982), in left arm and on 03Dec2021 at 23:15 as dose 3 (booster), single (Lot number: FJ8757) at the age of 70 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Rheumatoid arthritis" (ongoing); "linear IGA dermatosis" (unspecified if ongoing). Concomitant medication(s) included: ORENCIA, stop date: 02Jul2022; DAPSONE; HYDROXYCHLOROQUINE. Past drug history included: Enbrel, reaction(s): "Known allergies: Enbrel". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 04Jul2022, outcome "not recovered" and all described as "COVID 19 Treatment/Covid symptoms, Fever". The patient underwent the following laboratory tests and procedures: Pyrexia: (04Jul2022) 102; SARS-CoV-2 antibody test: (04Jul2022) Positive; (13Jul2022) Negative, notes: antigen test; (14Jul2022) Positive, notes: antigen test. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Rheumatoid arthritis flareup after 2nd and 3rd doses. Flareups was keep getting worse causing patient to start Orencia. Covid symptoms began on 03Jul2022, tested positive on 04Jul2022 with 102 fever. Started Paxlovid treatment in the afternoon of 05Jul2022 and completed on 10Jul2022. Tested Covid negative on antigen test 13Jul2022. Respiratory symptoms began evening of 13Jul2022 and tested positive on antigen test 14Jul2022.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200960543 Same patient, different drug, different event;US-PFIZER INC-202200966407 Same product, patient, different AEs, different dose;US-PFIZER INC-202200966412 Same product, patient, different AEs, different dose;
Headache, Myalgia, Fever, Diarrhea, sore throat Narrative:  Employee reports experiencing injection site pain/discomfort, fever, headaches, body aches, diarrhea, and a sore throat within about 4.5 hours from  receiving vaccine. Reports using Tylenol for symptom relief. Has not fully  recovered as of date of this report.  Other Relevant History:
Fever of 102F; Chills; Headache; Ringing ears; Trouble breathing; This is a spontaneous report from a contactable other healthcare professional, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the  left arm on 10Apr2021 at 16:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication included naproxen (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of  BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration  on an unknown date as a single dose for COVID-19 immunisation. On 11Apr2021 at 13:00, the patient experienced fever of 102 Fahrenheit, chills, headache, ringing ears and had trouble breathing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of fever of 102 Fahrenheit, chills, headache, ringing ears and trouble breathing were not resolved at the time of this report.  No follow-up attempts are needed; information about lot number cannot be obtained.
On 03/12/2021 at 0630 fell out of bed, wife witnessed tonic clonic seizure of 5+ minutes duration, when EMS arrived patient was postictal (confusion).
Patient given DT rather than DTaP as ordered. No adverse reaction; however, patient will be given an additional dose of DTaP to ensure pertussis coverage.
Headache, Myalgia, Arthralgia, Fever, chills, injection site pain  Narrative:
Patient received Td vaccination on 09/25/09 and developed redness and swelling at injection site, as well as a fever that lasted two days. Patient saw the doctor on 09/28/09. Patient recovered.
10 days after shot left arm below where vaccine was given swell Up like a raise ball with pain and redness and hot feeling. Arm is still sore and new in that area itching. Swelling went down next day. Still sore as of now but not red or swollen just itching.
This spontaneous report was received from another health professional regarding a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with a dose of improperly stored VARIVAX (Merck) (lot # K021935 expiry date 10-NOV-2016) (dose and route unknown). No adverse events were reported. Follow up information has been received from the reporting C.M.A. during a phone call on 04-NOV-2015. The medical assistant reported that she would have to research the request made for patient identifiers, lot numbers, expiration dates and dates of vaccination. This is one of the two reports received from the same reporter. Follow up information has been received from the C.M.A. via other source on 24-NOV-2015 concerning a patient of unknown age and gender. The reporter stated that the patient was vaccinated with a dose of improperly stored VARIVAX (Merck) on 20-MAY-2015. This was one of several reports received from the same reporter. Additional information has been requested. Reporter information, patient demographics, therapy start date, event onset date and narrative were updated.
Adverse Event Safety Officer Reports: Guest who received Pfizer vaccine (Lot #EW0164) reported feeling dizzy while in the Post Vaccination Area. Intervention\Treatment\Why it Happened Aid (EMT?s) called. (B\P: 110\64, P-97, R-22, Temp: 98.3, SPO2 ? 100) Guest was proved juice. EMT?s assessed and no further interventions indicated. Offered and accepted more observation time. Outcomes EMT?s assisted Guest to the Check-Out area and escorted to the exit area. Guest with no further complaints of being dizzy or discomforts.
Patient presented today for second dose of COVID vaccine. She tolerated her first dose well. She has h/o elevated BP and "flushed" feeling with various meds including once when she was doing a bowel prep for a colonoscopy. We decided to monitor her for 30 minutes and she felt fine throughout. As she was walking to her car she felt "flushed" and a bit light headed so she returned to the monitoring area. Initial BP was 189/77, pulse 110, O2 sat 100%. We brought her to the back room so she could sit in a recliner and remove her mask. Subsequent BP 186/77, pulse 86 then 184/69, pulse 80 about 20 minutes later. O2 sat remained upper 90s to 100%.  She continued to report feeling "flushed" and noted pressure/pain behind her left eye so we elected to call EMS (and this was also patient request to go to the ED) so she could be evaluated. She drove herself to appointment. Her plan was to call her son to have him meet her at the ED. She left via ambulance in stable condition.
heart felt like was coming out of my chest, and recorded heart rate of 150ppm; overwhelmed and out of breath, started getting worse; This spontaneous case was reported by a patient and describes the occurrence of HEART RATE INCREASED (heart felt like was coming out of my chest, and recorded heart rate of 150ppm) and DYSPNOEA (overwhelmed and out of breath, started getting worse) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concomitant products included HYDROXYCHLOROQUINE for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced HEART RATE INCREASED (heart felt like was coming out of my chest, and recorded heart rate of 150ppm) and DYSPNOEA (overwhelmed and out of breath, started getting worse). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Adverse event following immunisation, at an unspecified dose and frequency. On 07-Feb-2021, HEART RATE INCREASED (heart felt like was coming out of my chest, and recorded heart rate of 150ppm) had resolved. At the time of the report, DYSPNOEA (overwhelmed and out of breath, started getting worse) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Jan-2021, Heart rate: 150 (High) ppm. heart felt like was coming out of my chest. On 20-Jan-2021, Heart rate: 130-140 (High) heart was still racing at about 130-140 beats per minute. On 01-Feb-2021, Heart rate: 112-113 (High) heart rate was still 112-113 beat per minute at rest.. On 07-Feb-2021, Heart rate: normal (normal) heart rate normalized on Sunday072021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.